Literature DB >> 8964394

A human antibody binds to alpha-galactose receptors and mimics the effects of Clostridium difficile toxin A in rat colon.

C Pothoulakis1, U Galili, I Castagliuolo, C P Kelly, S Nikulasson, P K Dudeja, T A Brasitus, J T LaMont.   

Abstract

BACKGROUND & AIMS: Nearly all human sera contain an immunoglobulin G antibody (antigalactose) that binds the trisaccharide Gal alpha 1-3Gal beta 1-4GlcNAc expressed on cells from most mammals but not humans. Because the Clostridium difficile toxin A receptor in rodents contains this trisaccharide, the aim of this study was to examine whether antigalactose could mimic the enterotoxic effects of toxin A and bind to receptors containing this trisaccharide.
METHODS: Fluid secretion, [3H]-mannitol permeability, and release of rat mast cell protease II and prostaglandin E2 were measured after luminal exposure of rat colon to either purified human anti-galactose, control immunoglobulin G, toxin A, or buffer.
RESULTS: Toxin A (5 micrograms) and antigalactose (250 micrograms) but not control immunoglobulin (250 micrograms) stimulated colonic fluid secretion and caused increased mannitol permeability and rat mast cell protease II release. Antigalactose and toxin A and, to a lesser degree, control immunoglobulin G also stimulated release of prostaglandin E2, but only toxin A produced acute inflammation of rat colonic mucosa. Antigalactose and toxin A bound specifically to a single class of colonic brush border receptors with dissociation constants of 10(-6) mol/L and 5.4 x 10(-8) mol/L, respectively.
CONCLUSIONS: Fluid secretion, increased permeability, and mast cell activation occur in rat colon when toxin A or human antigalactose immunoglobulin G bind to receptors bearing the trisaccharide Gal alpha 1-3Gal beta 1-4GlcNAc.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8964394     DOI: 10.1053/gast.1996.v110.pm8964394

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  9 in total

1.  Studying the interaction of alpha-gal carbohydrate antigen and proteins by quartz-crystal microbalance.

Authors:  Yun Zhang; Vladislav Telyatnikov; Megahna Sathe; Xiangqun Zeng; Peng George Wang
Journal:  J Am Chem Soc       Date:  2003-08-06       Impact factor: 15.419

2.  Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa.

Authors:  I Castagliuolo; M F Riegler; L Valenick; J T LaMont; C Pothoulakis
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

3.  Crystal structure of receptor-binding C-terminal repeats from Clostridium difficile toxin A.

Authors:  Jason G S Ho; Antonio Greco; Maja Rupnik; Kenneth K-S Ng
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-12       Impact factor: 11.205

Review 4.  Clostridium difficile infection: molecular pathogenesis and novel therapeutics.

Authors:  Ardeshir Rineh; Michael J Kelso; Fatma Vatansever; George P Tegos; Michael R Hamblin
Journal:  Expert Rev Anti Infect Ther       Date:  2014-01       Impact factor: 5.091

5.  Human Clostridium difficile infection: altered mucus production and composition.

Authors:  Melinda A Engevik; Mary Beth Yacyshyn; Kristen A Engevik; Jiang Wang; Benjamin Darien; Daniel J Hassett; Bruce R Yacyshyn; Roger T Worrell
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-12-31       Impact factor: 4.052

6.  In vivo physiological and transcriptional profiling reveals host responses to Clostridium difficile toxin A and toxin B.

Authors:  Kevin M D'Auria; Glynis L Kolling; Gina M Donato; Cirle A Warren; Mary C Gray; Erik L Hewlett; Jason A Papin
Journal:  Infect Immun       Date:  2013-07-29       Impact factor: 3.441

7.  Human intestinal enteroids as a model of Clostridioides difficile-induced enteritis.

Authors:  Melinda A Engevik; Heather A Danhof; Alexandra L Chang-Graham; Jennifer K Spinler; Kristen A Engevik; Beatrice Herrmann; Bradley T Endres; Kevin W Garey; Joseph M Hyser; Robert A Britton; James Versalovic
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-03-30       Impact factor: 4.052

Review 8.  Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects.

Authors:  Stefano Di Bella; Paolo Ascenzi; Steven Siarakas; Nicola Petrosillo; Alessandra di Masi
Journal:  Toxins (Basel)       Date:  2016-05-03       Impact factor: 4.546

Review 9.  Non-Digestible Oligosaccharides and Short Chain Fatty Acids as Therapeutic Targets against Enterotoxin-Producing Bacteria and Their Toxins.

Authors:  Mostafa Asadpoor; Georgia-Nefeli Ithakisiou; Paul A J Henricks; Roland Pieters; Gert Folkerts; Saskia Braber
Journal:  Toxins (Basel)       Date:  2021-02-25       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.